Risk Factors in Breast Cancer Progression and Current Advances in Therapeutic Approaches to Knockdown Breast Cancer

@inproceedings{Amjad2018RiskFI,
  title={Risk Factors in Breast Cancer Progression and Current Advances in Therapeutic Approaches to Knockdown Breast Cancer},
  author={Amina Amjad and Iqra Ikram Khan and Zarfashan Kausar and Fatima O. Saeed and Laraib azhar and Pervez Anwar},
  year={2018}
}
  • Amina Amjad, Iqra Ikram Khan, +3 authors Pervez Anwar
  • Published 2018
  • Medicine
  • The complicated coding of tumorous cells requires emerging molecular biology tools for early diagnosis and for the better understandings of cancer progression. In spite of the advancement in diagnostic and therapeutic approaches to hit breast cancer, it is still a second major cause of cancerous deaths among women globally. In therapeutic vibes, deregulation in the expression of genes such as BRCA1, BRCA2, PIK3, RB, MDM2, TPK53 and HER2 involved in breast cancer prevalence. Furthermore… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 52 REFERENCES
    Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
    • 595
    • Open Access
    Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.
    • 301
    • Open Access
    Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications
    • 282
    • Open Access
    Nanoparticle-based theranostic agents.
    • 914
    • Open Access
    MicroRNA (miRNA) in cancer
    • 259
    • Open Access
    The promise of microRNA replacement therapy.
    • 479
    • Open Access